SAGITTARIUS at the EU Cancer Mission Conference 2025

Copenhagen, 4 December 2025

SAGITTARIUS was honoured to take part in the EU Cancer Mission Conference, a key European event dedicated to accelerating research and innovation in cancer care. As one of the flagship initiatives of the EU’s Horizon Europe framework, the Cancer Mission aims to improve the lives of more than 3 million people by 2030 through better cancer knowledge, prevention, early detection, and therapies, and improving quality of life.

The 2025 conference, titled “Advancing Cancer Care: Personalised Treatment and Innovation for All Europeans,” gathered oncologists, researchers, patients, and policymakers to discuss how Mission‑driven collaboration can transform cancer therapies. Held on 4 December 2025, 9:00 AM to 5:00 PM, in Copenhagen and online, the event served as an important platform to showcase scientific advances and strengthen cross‑country cooperation.

Driving Innovation for Cancer Patients Across Europe

The conference’s discussions were focused on advanced diagnostics techniques–such as liquid biopsy, AI-enhanced imaging, and multi-OMIC profiling technologies–, innovative biomarkers and treatments, holistic approaches to personalised care, and EU Cancer mission projects insights. The EU Cancer Mission Conference underscored the collective commitment of researchers, clinicians, institutions, and policymakers to accelerate innovation and ensure that scientific advances translate into equitable improvements in patient outcomes throughout Europe.

In this context, the SAGITTARIUS project’s vision to improve colon cancer care was presented by Dr Giorgio Patelli (IFOM ETS, Ospedale Niguarda, and Milan University), on behalf of the SAGITTARIUS clinical network. Dr Patelli presented the rationale and latest advancements of the SAGITTARIUS project, emphasising how ctDNA‑based molecular profiling via liquid biopsy may lead to personalised post-surgical treatment strategies for high-risk stage II and stage III colon cancer. “Personalised medicine is happening now and is making a real difference in patient care,” commented Dr Patelli.

SAGITTARIUS extends its thanks to the European Commission and to all participants who continue to drive the Mission’s objectives forward. Their shared efforts are vital to ensuring that precision oncology becomes a reality for every patient in every European region.